Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

179 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Synthesis and structure-activity relationships of a new model of arylpiperazines. 1. 2-[[4-(o-methoxyphenyl)piperazin-1-yl]methyl]-1, 3-dioxoperhydroimidazo[1,5-alpha]pyridine: a selective 5-HT1A receptor agonist.
López-Rodríguez ML, Rosado ML, Benhamú B, Morcillo MJ, Sanz AM, Orensanz L, Beneitez ME, Fuentes JA, Manzanares J. López-Rodríguez ML, et al. Among authors: fuentes ja. J Med Chem. 1996 Oct 25;39(22):4439-50. doi: 10.1021/jm960416g. J Med Chem. 1996. PMID: 8893838
Design and synthesis of S-(-)-2-[[4-(napht-1-yl)piperazin-1-yl]methyl]-1,4-dioxoperhydropyrrolo[1,2-a]pyrazine (CSP-2503) using computational simulation. A 5-HT1A receptor agonist.
López-Rodríguez ML, Morcillo MJ, Fernández E, Benhamú B, Tejada I, Ayala D, Viso A, Olivella M, Pardo L, Delgado M, Manzanares J, Fuentes JA. López-Rodríguez ML, et al. Among authors: fuentes ja. Bioorg Med Chem Lett. 2003 Apr 17;13(8):1429-32. doi: 10.1016/s0960-894x(03)00160-4. Bioorg Med Chem Lett. 2003. PMID: 12668005
Synthesis and structure-activity relationships of a new model of arylpiperazines. 8. Computational simulation of ligand-receptor interaction of 5-HT(1A)R agonists with selectivity over alpha1-adrenoceptors.
López-Rodríguez ML, Morcillo MJ, Fernández E, Benhamú B, Tejada I, Ayala D, Viso A, Campillo M, Pardo L, Delgado M, Manzanares J, Fuentes JA. López-Rodríguez ML, et al. Among authors: fuentes ja. J Med Chem. 2005 Apr 7;48(7):2548-58. doi: 10.1021/jm048999e. J Med Chem. 2005. PMID: 15801844
Design and synthesis of 2-[4-[4-(m-(ethylsulfonamido)-phenyl) piperazin-1-yl]butyl]-1,3-dioxoperhydropyrrolo[1,2-c]imidazole (EF-7412) using neural networks. A selective derivative with mixed 5-HT1A/D2 antagonist properties.
López-Rodríguez ML, Morcillo MJ, Fernández E, Rosado ML, Orensanz L, Beneytez ME, Manzanares J, Fuentes JA, Schaper KJ. López-Rodríguez ML, et al. Among authors: fuentes ja. Bioorg Med Chem Lett. 1999 Jun 21;9(12):1679-82. doi: 10.1016/s0960-894x(99)00254-1. Bioorg Med Chem Lett. 1999. PMID: 10397500
Synthesis and structure-activity relationships of a new model of arylpiperazines. 5. Study of the physicochemical influence of the pharmacophore on 5-HT(1a)/alpha(1)-adrenergic receptor affinity: synthesis of a new derivative with mixed 5-HT(1a)/d(2) antagonist properties.
López-Rodríguez ML, Morcillo MJ, Fernández E, Porras E, Orensanz L, Beneytez ME, Manzanares J, Fuentes JA. López-Rodríguez ML, et al. Among authors: fuentes ja. J Med Chem. 2001 Jan 18;44(2):186-97. doi: 10.1021/jm000929u. J Med Chem. 2001. PMID: 11170628
179 results